361 Capital’s Athenex, Inc. Common Stock ATNX Stock Holding History

361 Capital’s Portfolio ATNX Stock Details ATNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$909K	Sell	3,304 -514	-13%	-$109K	0.43%	63
2020 Q1	$591K	Buy	+3,818	New	+$961K	0.27%	204

Other funds holding ATNX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

361 Capital's ATNX Position: Q2 2020 in Review

361 Capital reduced its Athenex, Inc. Common Stock (ATNX) stake by 13% in Q2 2020, selling an estimated $109K and leaving 3,304 shares worth $909K. The position accounts for 0.43% of the portfolio, ranked #63.

361 Capital first reported a position in ATNX in Q1 2020 and has held it in 2 quarters since. 104 funds tracked by Wall St. Rank hold ATNX as of Q2 2020.

361 Capital held 3,304 shares of Athenex, Inc. Common Stock worth $909K as of Q2 2020.
361 Capital sold 514 Athenex, Inc. Common Stock shares in Q2 2020, an estimated $109K.
Athenex, Inc. Common Stock made up 0.43% of 361 Capital's portfolio in Q2 2020, its #63 holding.
361 Capital first reported a position in Athenex, Inc. Common Stock in Q1 2020 and has held it in 2 quarters since.
104 funds tracked by Wall St. Rank held Athenex, Inc. Common Stock as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.